Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)
Clinical trial NCT06241755 · RECRUITING
Trial details
- NCT number
- NCT06241755
- Sponsor
- Chengdu CoenBiotech Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-28
- Primary completion
- 2025-09-01
- Enrollment
- 412
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.